ANDA 74333, held by Teva Pharmaceuticals. Metoprolol Tartrate.
As of Nov 22, 2026, ANDA 74333 (Metoprolol Tartrate), held by Teva Pharmaceuticals, was first approved by FDA on Jan 27, 1994, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 27, 1994 | Original application | Approved | None posted |
| Metoprolol Tartrate50MG · tablet;oral | Metoprolol Tartrate | Discontinued |
| Metoprolol Tartrate100MG · tablet;oral | Metoprolol Tartrate | Discontinued |
| Mar 23, 1999 | Supplement 2Manufacturing | Approved | None posted |
| May 31, 1996 | Supplement 1Manufacturing | Approved | None posted |
| Jan 27, 1994 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters